Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 12/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.83 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.83 |
| ▸ | TSHR | P16473 | 8/20 | 0.83 |
| ▸ | HPGD | P15428 | 6/20 | 0.83 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.83 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.83 |
| ▸ | USP2 | O75604 | 4/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.66 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783049 | 0.91 | ALDH1A1 (0.85) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL13050537 | 0.91 | HSD17B10 (1.00) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL485095 | 0.81 | CYP2D6 (0.81) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL29400889 | 0.77 | PLD1 (1.00) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL7900 | 0.77 | PLD1 (1.00) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL893565 | 0.77 | PLD1 (1.00) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL29782931 | 0.77 | ALDH1A1 (1.00) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL13811463 | 0.77 | HDAC1 (0.51) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL14996516 | 0.76 | HSD17B10 (0.69) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR | |
| SCHEMBL27246564 | 0.76 | ALDH1A1 (0.71) | HSD17B10ALDH1A1CYP2D6CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| EP-2411381-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| WO-2010108651-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010108651-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | HSD17B10 4072/4885ALDH1A1 2086/4885CYP2D6 1926/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | HSD17B10 4072/4885ALDH1A1 2086/4885CYP2D6 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.